Dupilumab‐associated hypereosinophilia in patients treated for moderate‐to‐severe atopic dermatitis - Archive ouverte HAL Access content directly
Journal Articles Journal of the European Academy of Dermatology and Venereology Year : 2021

Dupilumab‐associated hypereosinophilia in patients treated for moderate‐to‐severe atopic dermatitis

(1) , (1) , (2) , (3) , (4) , (5) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (1)
1
2
3
4
5
6
7
8
9
10
11
12

Domains

Life Sciences [q-bio]

Hélène BILLARD  : Connect in order to contact the contributor

https://hal.inrae.fr/hal-03844087

Submitted on : Tuesday, November 8, 2022-3:13:48 PM

Last modification on : Sunday, November 27, 2022-5:54:08 PM

Not file

Dates and versions

hal-03844087 , version 1 (08-11-2022)

Identifiers

Cite

P. Marcant, P. Balayé, R. Merhi, F. Jendoubi, A. Nosbaum, et al.. Dupilumab‐associated hypereosinophilia in patients treated for moderate‐to‐severe atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 2021, 35 (6), pp.e394-e396. ⟨10.1111/jdv.17177⟩. ⟨hal-03844087⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

SSA UNIV-NANTES COMUE-NORMANDIE UNIROUEN SORBONNE-UNIVERSITE SU-MEDECINE INRAE PHAN NANTES-UNIVERSITE UNIV-UT3 UT3-TOULOUSEINP
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More